Skip to content
WeighLab

Rivo Health vs Aspire Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Rivo Health

Provider comparison

Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in.

Semaglutide / month
$149/moStarting dose, annual plan, compounded injection or oral
Tirzepatide / month
$199/moStarting dose, annual plan, compounded injection or oral
Index 71/100 · Grade CChecked October 2026

Aspire Health

Provider comparison

Shoppers in its 30 states who want compounded or brand-name GLP-1s with a full price list up front and a small, named clinical team.

Semaglutide / month
$129Per vial at 0.25–0.5 mg (a 5–10 week supply, compounded with B3; plus the required $49/mo care fee; $159–$189 per vial at 1–2.4 mg; brand Wegovy $199–$399 for a 4-week supply)
Tirzepatide / month
$149 per 4 weeksAt 2.5 mg (compounded with B3; plus the required $49/mo care fee; $249–$299 per vial at 5–15 mg; brand Zepbound $299–$449 for a 4-week supply)
Index 71/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 71/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Rivo Health
All 50 states
Aspire Health
30 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Rivo Health

Aspire Health

Semaglutide / month
Rivo Health: $149/moStarting dose, annual plan, compounded injection or oral
Aspire Health: $129Per vial at 0.25–0.5 mg (a 5–10 week supply, compounded with B3; plus the required $49/mo care fee; $159–$189 per vial at 1–2.4 mg; brand Wegovy $199–$399 for a 4-week supply)
Tirzepatide / month
Rivo Health: $199/moStarting dose, annual plan, compounded injection or oral
Aspire Health: $149 per 4 weeksAt 2.5 mg (compounded with B3; plus the required $49/mo care fee; $249–$299 per vial at 5–15 mg; brand Zepbound $299–$449 for a 4-week supply)
Semaglutide / year (modeled)
Rivo Health: $1,788
Aspire Health: $2,136Includes $49/mo care fee
Tirzepatide / year (modeled)
Rivo Health: $2,388
Aspire Health: $2,52513 charges, includes $49/mo care fee
State availability
Rivo Health: All 50 states
Aspire Health: 30 states
Oral / sublingual option listed
Rivo Health: Yes
Aspire Health: Not listed
Brand-name access listed
Rivo Health: Not confirmed
Aspire Health: Yes
Provider facts checked
Rivo Health: October 2026
Aspire Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Rivo Health

Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in.

Reasons to consider it

  • Bundles a membership (unlimited provider visits, dietitian, coaching) into the plan at no separately-billed cost
  • Large, established program with a stated 115,000+ member base and 4.7 Trustpilot rating
  • Both injectable and oral compounded options for semaglutide and tirzepatide

What to weigh up

  • The headline $149/$199 prices require a 12-month annual-plan commitment — the genuine month-to-month rate, shown crossed out on the same page, is $279/mo and $389/mo, 87-95% higher
  • The site doesn't name its compounding pharmacy partner
  • No LegitScript certification shown on the site

Aspire Health

Shoppers in its 30 states who want compounded or brand-name GLP-1s with a full price list up front and a small, named clinical team.

Reasons to consider it

  • Both compounded and brand-name options (Wegovy and Zepbound), each priced dose by dose before you book
  • Free first consultation, and you pay only if you decide to move forward
  • Lab orders with interpretation are part of the monthly care; the labs themselves can be billed to insurance

What to weigh up

  • The $49/mo care fee is billed on top of the medication (its FAQ still says $75/mo for the program, so confirm the fee before you enroll)
  • The price rises with your dose, and a vial lasts anywhere from four to ten weeks, so the monthly cost depends on your dose
  • Lab costs aren't included in the care fee

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Rivo HealthAspire Health
Normalized Cost/Month
Rivo Health:
62/100
Aspire Health:
66/100
Price Transparency
Rivo Health:
78/100
Aspire Health:
70/100
Nationwide Access
Rivo Health:
86/100
Aspire Health:
66/100
Formulation Options
Rivo Health:
77/100
Aspire Health:
79/100
Clinical Oversight
Rivo Health:
79/100
Aspire Health:
85/100
Contract Flexibility
Rivo Health:
33/100
Aspire Health:
67/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.